All Stories

  1. Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements

    Article • September 2020, European Respiratory Society (ERS)

    Dr Nicola A. Hanania

  2. Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD

    Article • ERJ Open Research, April 2020, European Respiratory Society (ERS)

    Dr Nicola A. Hanania

  3. Response

    Article • CHEST Journal, December 2019, Elsevier

    Dr Nicola A. Hanania

  4. Radiation-Induced Lung Injury

    Article • CHEST Journal, July 2019, Elsevier

    Dr Nicola A. Hanania

  5. Novel therapeutic targets and drug development for the precision treatment of COPD

    Article • Expert Review of Precision Medicine and Drug Development, May 2019, Taylor & Francis

    Dr Nicola A. Hanania

  6. Targeting IL-5 in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Dr Nicola A. Hanania

  7. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Dr Nicola A. Hanania

  8. Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma

    Article • ClinicoEconomics and Outcomes Research, April 2019, Dove Medical Press

    Dr Nicola A. Hanania

  9. Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2018, Dove Medical Press

    Dr Nicola A. Hanania

  10. Severe Acute Asthma

    Article • October 2018, Wiley

    Dr Nicola A. Hanania

  11. New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2018, Dove Medical Press

    Mario Cazzola, Dr Nicola A. Hanania

  12. Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease

    Article • Annals of the American Thoracic Society, August 2018, American Thoracic Society

    Dr Nicola A. Hanania

  13. How does race/ethnicity influence pharmacological response to asthma therapies?

    Article • Expert Opinion on Drug Metabolism & Toxicology, March 2018, Taylor & Francis

    Mario Cazzola, Dr Nicola A. Hanania

  14. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2018, Dove Medical Press

    Dr Nicola A. Hanania

  15. Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

    Article • Allergy, September 2017, Wiley

    Dr Nicola A. Hanania

  16. Factors associated with depressive symptoms in uncontrolled asthmatics

    Article • Journal of Asthma, July 2017, Taylor & Francis

    Dr Nicola A. Hanania

  17. Safety of inhaled long-acting anti-muscarinic agents in COPD

    Article • Postgraduate Medicine, April 2017, Taylor & Francis

    Miss Gill Sperrin, Suzanne Lareau, Dr Nicola A. Hanania

  18. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications

    Article • Clinical & Experimental Allergy, January 2017, Wiley

    Dr Nicola A. Hanania

  19. Asthma and Aging

    Article • January 2016, Springer Science + Business Media

    Dr Nicola A. Hanania

  20. A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2015, Dove Medical Press

    Mario Cazzola, Dr Nicola A. Hanania

  21. Hospital management of acute exacerbations of chronic obstructive pulmonary disease

    Article • Journal of Hospital Medicine, March 2015, Frontline Medical Communications, Inc.

    Dr Nicola A. Hanania

  22. Optimizing care of your patients with COPD

    Article • Nursing Research and Reviews, February 2014, Taylor & Francis

    Dr Nicola A. Hanania

  23. Evaluating the Safety of COPD Medications

    Article • CHEST Journal, October 2013, Elsevier

    Dr Nicola A. Hanania

  24. Ten years of tiotropium: clinical impact and patient perspectives

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2013, Taylor & Francis

    Dr Abebaw M Yohannes , Dr Nicola A. Hanania

  25. The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2013, Taylor & Francis

    Dr Nicola A. Hanania

  26. Guest Editorial

    Article • Respiratory Medicine, December 2012, Elsevier

    Dr Nicola A. Hanania

  27. A Unified Front Against COPD

    Article • CHEST Journal, September 2011, Elsevier

    Dr Nicola A. Hanania

  28. COPD

    Article • January 2011, Springer Science + Business Media

    Dr Nicola A. Hanania

  29. Pharmacological Therapy: Bronchodilators

    Article • October 2010, Springer Science + Business Media

    Dr Nicola A. Hanania

  30. Chapter-16 Endobronchial Tuberculosis

    Article • January 2009, Jaypee Brothers Medical Publishing

    Dr Nicola A. Hanania

  31. Targeting Airway Inflammation in Asthma

    Article • CHEST Journal, April 2008, Elsevier

    Dr Nicola A. Hanania

  32. Bronchodilators: Beta2-Agonists and Anticholinergics

    Article • January 2008, Elsevier

    Dr Nicola A. Hanania

  33. Asthma in Older Adults

    Article • Clinics in Chest Medicine, December 2007, Elsevier

    Dr Nicola A. Hanania

  34. Ipratropium Bromide HFA

    Article • Treatments in Respiratory Medicine, January 2005, Springer Science + Business Media

    Dr Nicola A. Hanania

  35. Differentiating Asthma and COPD Patients

    Article • CHEST Journal, August 2004, Elsevier

    Dr Nicola A. Hanania

  36. Inhaled Salmeterol/Fluticasone Propionate Combination in Chronic Obstructive Pulmonary Disease

    Article • American Journal of Respiratory Medicine, August 2002, Springer Science + Business Media

    Dr Nicola A. Hanania